“Haemophilus influenzae Type b/Polyribosylribitol Phosphate-Tetanus (Hib/PRP-T) Vaccine Safety, Phase I Study” (2015) International Journal of Integrated Health Sciences, 3(2), pp. 55–59. doi:10.15850/ijihs.v3n2.584.